Iron Age Populations Ate Blue Cheese and Drank Beer, Their Feces Suggest
Analysis of fecal samples from the Bronze Age, Iron Age and the Baroque period provide new insights into the diet and gut microbiomes of ancient populations. The study – published in Current Biology – suggests that Iron Age populations enjoyed the consumption of blue cheese and beer.
Air Pollution Reduces Sperm Count Through Brain Inflammation
Researchers have long known that air pollution can increase the risk of disorders such as obesity, diabetes, and fertility, but they did not know the exact mechanism for how it can lead to these health conditions. Now researchers have shown how air pollution reduces sperm count in mice by causing inflammation in the brain.
Agreement to Streamline Drug Development
Invitrogen will combine its Voltage Sensor Probes ion channel reagents with PerkinElmer’s CellLux™ Fluorescence Cellular Screening Platform.
Alnylam Grants Qiagen License to Kreutzer-Limmer Patents
This patent family, owned by Alnylam, covers small interfering RNAs and their use to mediate RNAi in mammalian cells.
Gene-IT Licenses GenomeQuest™ to Canadian Intellectual Property Office
GenomeQuest™ is a genomic information service and software application that provides sequence comparison solutions for biological and patent investigators.
ISB Adopts Kreatech's ULS™ Nucleic Acid Labeling Technology
ULS™ is now the preferred labeling method for both bacterial gene expression profiling and Chip on Chip assays that have been developed at the ISB.
Positive Beta Site Results for Sequenom's iPLEX™ Assay Trigger Multiple Sales
Sequenom's iPLEX assay is very useful for evaluating targeted sets of SNPs and also expedites follow up work in the validation of genome scan results.
Researchers Create Functioning Artificial Proteins
Researchers have discovered a set of simple rules and have now employed these rules to create artificial proteins.
Sareum Collaborates with Infinity Pharmaceuticals
Sareum will utilise its skills in high throughput protein expression, purification and structure determination to illustrate the precise nature of how Infinity’s potential drug candidates interact with target receptor proteins.
Discovery of Blood Serum Biomarkers for Breast Cancer
Power3 Medical Products, Inc. has discovered a group of breast cancer protein biomarkers in preliminary studies of blood serum.
NuGEN Granted Patent for RNA Amplification Technology
This patent establishes protection around the company's innovative linear, isothermal RNA amplification technology.
Oxford Gene Technology Grants Microarray Licence to Febit
Agreement strengthens febit’s IP and places febit in a position to successfully market Geniom® worldwide.